In a report issued on January 4, Steven Valiquette from Barclays maintained a Hold rating on Molina Healthcare (MOH), with a price target of $129. The company’s shares closed on Friday at $109.66.
According to TipRanks.com, Valiquette is a 4-star analyst with an average return of 4.1% and a 48.2% success rate. Valiquette covers the Services sector, focusing on stocks such as AmerisourceBergen Corporation, Patterson Companies Inc, and WellCare Health Plans.
Currently, the analyst consensus on Molina Healthcare is a Moderate Buy with an average price target of $163.60, implying a 49.2% upside from current levels. In a report issued on January 3, Wolfe Research also downgraded the stock to Hold.
.
See today’s analyst top recommended stocks >>
Based on Molina Healthcare’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $4.7 billion and net profit of $197 million. In comparison, last year the company earned revenue of $4.95 billion and had a GAAP net loss of $262 million.
Based on the recent corporate insider activity of 88 insiders, corporate insider sentiment is negative on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Molina Healthcare, Inc. engages in the provision of health care services. It operates through the Health Plans and Molina Medicaid Solutions segments. The Health Plans segment consists of health plans in 11 states and the Commonwealth of Puerto Rico, and includes our direct delivery business.
